Analyst Price Target is $195.00
▲ +15.65% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for AptarGroup in the last 3 months. The average price target is $195.00, with a high forecast of $215.00 and a low forecast of $185.00. The average price target represents a 15.65% upside from the last price of $168.61.
Current Consensus is
Buy
The current consensus among 5 contributing investment analysts is to buy stock in AptarGroup. This rating has held steady since December 2023, when it changed from a Moderate Buy consensus rating.
AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, and aerosol valves to the digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
Read More